Business · 1 sources covering this

Ipca Labs Up 36% In One Year; Nomura Raises Target, Sees 19% Upside — Check Why

Nomura has raised its FY27/FY28 sales estimates by around 2.5%, EBITDA estimates by 9% and PAT estimates by 13%, reflecting the stronger momentum and upgraded guidance.

Share:WhatsApp X Reddit Facebook LinkedIn

Coverage spectrum

0 L · 1 C · 0 R

How 1 sources are covering this

NDTVCenter·2h ago
Ipca Labs Up 36% In One Year; Nomura Raises Target, Sees 19% Upside — Check Why
Nomura has raised its FY27/FY28 sales estimates by around 2.5%, EBITDA estimates by 9% and PAT estimates by 13%, reflecting the stronger momentum and upgraded guidance.
Read at NDTV →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://hindustansphere.com/embed/cluster/0ee3389872dacf0e6df9564319e5ecb2d42dacd6"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="Ipca Labs Up 36% In One Year; Nomura Raises Target, Sees 19% Upside — Check Why"></iframe>

Ipca Labs Up 36% In One Year; Nomura Raises Target, Sees 19% Upside — Check Why

How 1 sources are covering this

Ipca Labs Up 36% In One Year; Nomura Raises Target, Sees 19% Upside — Check Why

More from Business

Tube Investments share price rallies 9% post Q1 earnings commentary

Two new business dailies set for launch in India after nearly 18 years

4,192 cases pending against MPs, MLAs; 14 out of 28 chief ministers face serious criminal charges: Supreme Court told

MCX planning to invest ₹200 cr to start coal, minerals trading platforms

Reader

Trust & legal

Across the network